CBLL

Healthcare Medical Devices

CeriBell, Inc.

$23.69

+0.08 +0.34% today

Price History

Not enough data

Key Stats

Market Cap

909.18M

Avg Volume

373,476

EPS

-$1.76

52W High

$25.63

52W Low

$10.85

Div. Yield

0.0%

Analyst Ratings

Buy

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

Forward P/E

-14.69

P/B Ratio

7.06

P/S Ratio

8.92

EV/EBITDA

-11.65

EV/Revenue

7.86

Margins

Gross Margin 88.9%

Operating Margin (71.1%)

Net Margin (64.7%)

EBITDA Margin (67.5%)

Growth & Returns

Revenue Growth (YoY)

32.5%

Return on Equity

(43.9%)

Return on Assets

(23.4%)

Liquidity & Leverage

Current Ratio

9.18

Quick Ratio

8.45

Debt / Equity

0.17

Total Cash

129.26M

Total Debt

21.91M

About

CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm. In addition, it operates an EEG portal, which enables real-time remote access to a patient's EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.